BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19114340)

  • 1. [Role of Ca2+/calmodulin-dependent calcineurin signaling pathway in neuropeptide Y-induced cardiac hypertrophy in rats].
    Li XY; Chen MS; Huang SH; Dong Q; Li YH; Zhang S; Liu ZX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2139-41. PubMed ID: 19114340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats.
    Chen M; Li X; Dong Q; Li Y; Liang W
    Regul Pept; 2005 Feb; 125(1-3):9-15. PubMed ID: 15582708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
    Zhou DX; Liang QS; He XX; Zhan CY
    Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes.
    Wang LN; Wang C; Lin Y; Xi YH; Zhang WH; Zhao YJ; Li HZ; Tian Y; Lv YJ; Yang BF; Xu CQ
    Biochem Biophys Res Commun; 2008 May; 369(2):584-9. PubMed ID: 18295598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dl-praeruptorin A on cultured neonatal rat ventricular cardiomyocytes with hypertrophy induced by endothelin-1.
    Tu X; Miao L; Kang Y; Xia H; Tu JW; Wang Q; Tu Q; Wang JM; Hao H
    Methods Find Exp Clin Pharmacol; 2009 May; 31(4):231-6. PubMed ID: 19557200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin II induced cardiac hypertrophy is blocked by PTEN via suppressing Ca2+/Calcineurin pathway].
    Yu LJ; Zhu SJ; Zhou YZ; Wang J; Tian Y; Zhu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):541-5. PubMed ID: 16842674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
    Merten KE; Jiang Y; Feng W; Kang YJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The signal transduction pathway causing the synergistic hypertrophic effects of neuropeptide Y and norepinephrine on primary cardiomyocyte.
    Zeng C; Zhou Y; Liu G; Sun W
    Neuropeptides; 2001; 35(5-6):211-8. PubMed ID: 12030804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo.
    Zhang HG; Li XH; Zhou JZ; Liu Y; Jia Y; Yuan ZB
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1276-81. PubMed ID: 17973867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload.
    Bell D; Allen AR; Kelso EJ; Balasubramaniam A; McDermott BJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):581-91. PubMed ID: 12388639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 induced hypertrophic effect in neonatal rat cardiomyocytes: involvement of Na+/H+ and Na+/Ca2+ exchangers.
    Dulce RA; Hurtado C; Ennis IL; Garciarena CD; Alvarez MC; Caldiz C; Pierce GN; Portiansky EL; Chiappe de Cingolani GE; Camilión de Hurtado MC
    J Mol Cell Cardiol; 2006 Nov; 41(5):807-15. PubMed ID: 16859700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
    Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Ca2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy.
    Zobel C; Rana OR; Saygili E; Bölck B; Saygili E; Diedrichs H; Reuter H; Frank K; Müller-Ehmsen J; Pfitzer G; Schwinger RH
    Cardiology; 2007; 107(4):281-90. PubMed ID: 17264507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes.
    Vlasblom R; Muller A; Musters RJ; Zuidwijk MJ; Van Hardeveld C; Paulus WJ; Simonides WS
    Cardiovasc Res; 2004 Aug; 63(3):537-44. PubMed ID: 15276479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role and regulation of calcineurin-dependent signal pathway in cardiac hypertrophy of rats].
    Fu MG
    Sheng Li Ke Xue Jin Zhan; 2001 Jan; 32(1):52-4. PubMed ID: 12545778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
    Ennis IL; Garciarena CD; Escudero EM; Pérez NG; Dulce RA; Camilión de Hurtado MC; Cingolani HE
    Can J Physiol Pharmacol; 2007; 85(3-4):301-10. PubMed ID: 17612638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.